TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer August 30, 2013
TCL Archive Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023 December 13, 2013